InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Pelthos Therapeutics Inc.

PTHS Clue Score29
United States Fiscal year ends December CIK 0001919246 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Matthew Pauls
2 Oct 2026
Director
Sold on a plan
786
$21.00
$16.51K
Ezra M Friedberg
2 Oct 2026
Director
Sold on a plan
558
$20.72
$11.56K
Peter Greenleaf
2 Oct 2026
Director
Sold on a plan
797
$21.17
$16.87K
Peter Greenleaf
2 Jul 2026
Director
Sold on a plan
85
$27.27
$2.32K
Peter Greenleaf
2 Jul 2026
Director
Sold on a plan
712
$26.00
$18.51K
Matthew Pauls
2 Jul 2026
Director
Sold on a plan
94
$27.36
$2.57K
Matthew Pauls
2 Jul 2026
Director
Sold on a plan
692
$26.00
$17.99K
Ezra M Friedberg
2 Jul 2026
Director
Sold on a plan
24
$27.33
$655.81
Ezra M Friedberg
2 Jul 2026
Director
Sold on a plan
534
$26.03
$13.90K
Ezra M Friedberg
15 Jun 2026
Director
Sold on a plan
59
$27.94
$1.65K
Ezra M Friedberg
15 Jun 2026
Director
Sold on a plan
224
$27.12
$6.08K
Peter Greenleaf
2 Apr 2026
Director
Sold on a plan
377
$21.36
$8.05K
Peter Greenleaf
2 Apr 2026
Director
Sold on a plan
420
$20.52
$8.62K
Matthew Pauls
2 Apr 2026
Director
Sold on a plan
371
$21.36
$7.93K
Matthew Pauls
2 Apr 2026
Director
Sold on a plan
415
$20.52
$8.51K
Ezra M Friedberg
2 Apr 2026
Director
Sold on a plan
265
$21.36
$5.66K
Ezra M Friedberg
2 Apr 2026
Director
Sold on a plan
293
$20.51
$6.01K
Richard Malamut
2 Apr 2026
Director
Sold on a plan
280
$21.36
$5.98K
Richard Malamut
2 Apr 2026
Director
Sold on a plan
310
$20.51
$6.36K
Show all 26 transactions →

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 35,633
History held since 23 Feb 2024